Form 8-K - Current report:
SEC Accession No. 0001193125-25-283314
Filing Date
2025-11-14
Accepted
2025-11-14 17:16:14
Documents
14
Period of Report
2025-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d39095d8k.htm   iXBRL 8-K 30697
2 EX-99.1 d39095dex991.htm EX-99.1 100070
6 GRAPHIC g39095g1115023958880.jpg GRAPHIC 3678
  Complete submission text file 0001193125-25-283314.txt   268637

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rptx-20251114.xsd EX-101.SCH 2512
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptx-20251114_lab.xml EX-101.LAB 18666
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptx-20251114_pre.xml EX-101.PRE 11673
16 EXTRACTED XBRL INSTANCE DOCUMENT d39095d8k_htm.xml XML 3899
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 251488210
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)